Group One Trading’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,432
| Closed | -$118K | – | 8108 |
|
|
2024
Q3 | $105K | Sell |
1,432
-5,209
| -78% | -$391K | ﹤0.01% | 4139 |
|
|
2024
Q2 | $455K | Sell |
6,641
-964
| -13% | -$66.9K | ﹤0.01% | 2651 |
|
|
2024
Q1 | $526K | Sell |
7,605
-5,913
| -44% | -$406K | ﹤0.01% | 2675 |
|
|
2023
Q4 | $968K | Buy |
+13,518
| New | +$778K | ﹤0.01% | 2480 |
|
|
2023
Q1 | – | Sell |
-6,984
| Closed | -$338K | – | 8101 |
|
|
2022
Q4 | $370K | Buy |
6,984
+5,534
| +382% | +$277K | ﹤0.01% | 3318 |
|
|
2022
Q3 | $67K | Buy |
+1,450
| New | +$75.7K | ﹤0.01% | 5155 |
|
|
2022
Q1 | – | Sell |
-9,541
| Closed | -$495K | – | 8874 |
|
|
2021
Q4 | $499K | Sell |
9,541
-18,087
| -65% | -$760K | ﹤0.01% | 4134 |
|
|
2021
Q3 | $1.03M | Buy |
27,628
+15,834
| +134% | +$550K | ﹤0.01% | 3379 |
|
|
2021
Q2 | $481K | Sell |
11,794
-2,190
| -16% | -$81K | ﹤0.01% | 4256 |
|
|
2021
Q1 | $474K | Buy |
+13,984
| New | +$485K | ﹤0.01% | 4098 |
|
|
2020
Q4 | – | Sell |
-16,132
| Closed | -$424K | – | 7105 |
|
|
2020
Q3 | $414K | Sell |
16,132
-56,221
| -78% | -$1.28M | ﹤0.01% | 3013 |
|
|
2020
Q2 | $1.86M | Buy |
+72,353
| New | +$1.46M | 0.01% | 1516 |
|
|
2019
Q4 | – | Sell |
-53,244
| Closed | -$639K | – | 5722 |
|
|
2019
Q3 | $398K | Buy |
+53,244
| New | +$511K | ﹤0.01% | 2528 |
|
|
2019
Q1 | – | Sell |
-19,561
| Closed | -$250K | – | 5471 |
|
|
2018
Q4 | $223K | Sell |
19,561
-33,980
| -63% | -$549K | ﹤0.01% | 2602 |
|
|
2018
Q3 | $1.16M | Sell |
53,541
-15,145
| -22% | -$317K | 0.01% | 1585 |
|
|
2018
Q2 | $1.21M | Sell |
68,686
-5,995
| -8% | -$122K | 0.01% | 1529 |
|
|
2018
Q1 | $1.57M | Buy |
74,681
+16,499
| +28% | +$321K | 0.02% | 1177 |
|
|
2017
Q4 | $842K | Buy |
58,182
+20,096
| +53% | +$310K | 0.01% | 1856 |
|
|
2017
Q3 | $601K | Buy |
38,086
+24,316
| +177% | +$357K | 0.01% | 1934 |
|
|
2017
Q2 | $171K | Buy |
13,770
+9,458
| +219% | +$110K | ﹤0.01% | 2758 |
|
|
2017
Q1 | $70K | Sell |
4,312
-523
| -11% | -$7.57K | ﹤0.01% | 3206 |
|
|
2016
Q4 | $73K | Sell |
4,835
-1,611
| -25% | -$22.8K | ﹤0.01% | 3025 |
|
|
2016
Q3 | $98K | Buy |
+6,446
| New | +$261K | ﹤0.01% | 2936 |
|
|
2016
Q2 | – | Sell |
-17,534
| Closed | -$630K | – | 5005 |
|
|
2016
Q1 | $487K | Buy |
17,534
+4,001
| +30% | +$133K | 0.01% | 1705 |
|
|
2015
Q4 | $728K | Buy |
13,533
+1,242
| +10% | +$62.6K | 0.01% | 1539 |
|
|
2015
Q3 | $492K | Buy |
12,291
+3,760
| +44% | +$123K | 0.01% | 1797 |
|
|
2015
Q2 | $273K | Buy |
+8,531
| New | +$216K | ﹤0.01% | 2302 |
|
Other funds holding ITCI
Group One Trading's ITCI Position: Q4 2024 in Review
Group One Trading sold out of Intra-Cellular Therapies Inc. (ITCI) in Q4 2024, closing a stake of 1,432 shares — an estimated $118K sold.
Group One Trading first reported a position in ITCI in Q2 2015 and held it in 27 quarters. The position peaked at $1.86M in Q2 2020. 387 funds tracked by Wall St. Rank hold ITCI as of Q4 2024.
- Group One Trading reported no remaining Intra-Cellular Therapies Inc. position as of Q4 2024 after selling out during the quarter.
- Group One Trading sold 1,432 Intra-Cellular Therapies Inc. shares in Q4 2024, an estimated $118K.
- Group One Trading first reported a position in Intra-Cellular Therapies Inc. in Q2 2015 and held it in 27 quarters.
- Group One Trading's Intra-Cellular Therapies Inc. position peaked at $1.86M in Q2 2020.
- 387 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q4 2024.
Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.